VYNE Therapeutics Inc. Common Stock (VYNE) stock analysis and AI prediction
The company facts of VYNE Therapeutics Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About VYNE Therapeutics Inc. Common Stock
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $30.8 million
- Size
- Micro cap
- Employees
- 10
- Headquarters
- BRIDGEWATER, NJ
- Listed since
- Jan. 25, 2018
- Website
- vynetherapeutics.com
More Healthcare stocks
Other micro cap stocks
Keep going
VYNE questions
What is the AI prediction for VYNE stock?
Each market day our model rates VYNE Therapeutics Inc. Common Stock (VYNE) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the VYNE prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for VYNE?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see VYNE options?
The VYNE options page opens its calls and puts, with price, volume, implied volatility and the Greeks.